Pular para o conteúdo principal

Insights

Cardiovascular Research, Explained

Plain-language articles on clinical trials, conditions, and procedures -- written for patients and partners.

Site Operations

Keeping principal investigators engaged when enrollment stalls

November 17, 2026Julio G. Martinez-Clark

A principal investigator (PI) does not disengage because enrollment is slow. A PI disengages when the trial goes quiet — when weeks pass with no update on screening, no visibility into referrals, and no recognition for the chart review and pre-screening work already done. Sites that keep a PI engaged through a slow stretch do three things: they keep the PI in the loop with a short, regular update, they tie compensation to defined activities rather than enrollment alone, and they ask directly what is slowing referrals instead of assuming it is motivation.

Read Keeping principal investigators engaged when enrollment stalls

Site Operations

Budgeting long-term record storage: the line item sites discover at closeout

November 17, 2026Julio G. Martinez-Clark

Record storage is not a closeout task. It is a multi-year obligation that starts the day a trial closes, and the sites that price it at signing — as its own annual budget line, split between physical and electronic records, with the retention period agreed in writing — are the ones that do not discover the cost years later, when the sponsor relationship has moved on and there is no amendment left to negotiate.

Read Budgeting long-term record storage: the line item sites discover at closeout

Site Operations

Mobile research units: which visits actually move — and which have to stay in clinic

November 14, 2026Julio G. Martinez-Clark

A mobile research unit — a van or trailer equipped for study visits outside the clinic — solves a real access problem, but it does not move a whole protocol off-site. The visits that move safely are routine, low-acuity assessments: vital signs, blood draws, and electrocardiograms (ECGs) performed by trained staff with the right equipment. The visits that stay in clinic are infusions, complex procedures, and anything that could need immediate escalation. Everything in between is a sponsor decision, and it has to be made — with protocol language and budget agreed — before the van is treated as a recruitment tool.

Read Mobile research units: which visits actually move — and which have to stay in clinic

Site Operations

Your clinical trial management system (CTMS) tracks invoices, not follow-ups: a site accounts receivable routine that actually collects

November 11, 2026Julio G. Martinez-Clark

A clinical trial management system (CTMS) is good at recording that an invoice was issued. It is poor at making sure the invoice gets paid. Sites that rely on their CTMS for accounts receivable (A/R) end up with a complete list of invoices and an incomplete picture of what is owed, because the system tracks billing events, not the follow-up each unpaid invoice still needs. The fix is a small routine that lives outside the CTMS: one aging tracker, pulled weekly, reviewed at 30, 60, and 90 days, with one named owner and one named next action for every overdue line.

Read Your clinical trial management system (CTMS) tracks invoices, not follow-ups: a site accounts receivable routine that actually collects

Site Operations

The retention work between visits: how to price budget amendments for long-term cardiovascular trials

November 11, 2026Julio G. Martinez-Clark

Long-term cardiovascular (CV) trials do not lose participants at the annual visit. They lose them in the long, quiet stretch between visits, when nobody is funded to make the contact attempts, keep vital status current, and keep the principal investigator (PI) reviewing follow-up data. Most budgets pay for the visit itself and leave that between-visit retention work unfunded, so sites absorb it until they cannot. A budget amendment fixes the problem only if it prices the right thing: an annual amount tied to the active follow-up population, with the oversight work named for what the protocol actually requires.

Read The retention work between visits: how to price budget amendments for long-term cardiovascular trials

Site Operations

Electronic RECIST workflow: named readers, second reads, and one standard operating procedure (SOP) for the audit trail

November 7, 2026Julio G. Martinez-Clark

RECIST disagreements are usually handoff failures, not software failures. One named trained reader per study, a second read for borderline lesions, trained backups, and one SOP for capture, measurement, and filing create an audit trail that stands on its own.

Read Electronic RECIST workflow: named readers, second reads, and one standard operating procedure (SOP) for the audit trail

Site Operations

Equipment maintenance intervals: what the manual requires vs. what your SOP should set — and why inconsistency creates findings

November 6, 2026Julio G. Martinez-Clark

If QA cites a manufacturer requirement, ask for the manual page. When the manual is silent, set a defensible interval in your SOP, log every event — inconsistency is what creates findings.

Read Equipment maintenance intervals: what the manual requires vs. what your SOP should set — and why inconsistency creates findings

Site Operations

One source of truth for pre-screening: why double entry between your tracker and the sponsor system creates errors

November 6, 2026Julio G. Martinez-Clark

Entering clinical data in both an internal tracker and the sponsor system creates discrepancies and PHI exposure. Work in the system of record; keep the internal list minimal — identifier, status, next action.

Read One source of truth for pre-screening: why double entry between your tracker and the sponsor system creates errors

Site Operations

Choosing a clinical trial management system (CTMS): sandbox-test it against your own standard operating procedures (SOPs) before you switch

November 6, 2026Julio G. Martinez-Clark

Vendor demos sell the demo. Build a test study from your own SOPs in the sandbox and make every candidate CTMS run it end to end — then price integrations, the AI roadmap, and switching costs.

Read Choosing a clinical trial management system (CTMS): sandbox-test it against your own standard operating procedures (SOPs) before you switch

For Sponsors

Building a site quality assurance (QA) program sponsors can audit: internal audits, corrective and preventive action (CAPA), and training records

November 6, 2026Julio G. Martinez-Clark

Sponsors ask how a site audits itself. A written QA plan, scheduled internal audits, CAPA discipline, and role-based training records make a standalone site read as inspection-ready.

Read Building a site quality assurance (QA) program sponsors can audit: internal audits, corrective and preventive action (CAPA), and training records

Regulatory Strategy

When sponsors supply routine-care meds for free: coverage analysis, inducement risk, and the opt-out to negotiate before you sign

November 6, 2026Julio G. Martinez-Clark

Free sponsor-supplied routine-care medications change your coverage analysis and raise inducement questions. Work through both, avoid the billing traps, and negotiate the opt-out before you sign.

Read When sponsors supply routine-care meds for free: coverage analysis, inducement risk, and the opt-out to negotiate before you sign

early feasibility study

Protocol feasibility for catheter-based cardiovascular devices: designing first-in-human endpoints for same-day observation

October 26, 2026Amavita Editorial (AI-assisted) AI-assisted

How to design early feasibility protocols for catheter-based devices with same-day observation, and what sponsors check when a US cardiology site brings in an outside implanting surgeon or procedure operator.

Read Protocol feasibility for catheter-based cardiovascular devices: designing first-in-human endpoints for same-day observation

cardiovascular clinical trials

From heart failure to structural interventions: what a dedicated Miami cardiovascular clinical site actually executes

October 13, 2026Amavita Editorial (AI-assisted) AI-assisted

Indication map, diagnostics, and same-day Phase 1 work (2 operating rooms and 5 recovery beds in a licensed Kendall cardiovascular ASC) at Amavita Research — without overnight or non-CV claims.

Read From heart failure to structural interventions: what a dedicated Miami cardiovascular clinical site actually executes

Site Operations

Buying Used Equipment for a Trial Site: The Qualification Checks That Matter More Than Price

October 13, 2026Julio G. Martinez-Clark

Used equipment can build a good site — or quietly disqualify it. Before buying a used ECG or other device for trial work: verify the calibration and service paper trail, confirm the digital export formats central laboratories require, budget IQ/OQ qualification, and run the total cost of ownership.

Read Buying Used Equipment for a Trial Site: The Qualification Checks That Matter More Than Price